Akin Akinc, Ph.D., Associate Director, Research, Alnylam Pharmaceuticals, Inc.
Kathryn L. Ackley, Ph.D., Vice President, Business Development and Project Management, Girindus, USA
Dr. Hüseyin Aygün, CSO, Nucleic Acid Technologies, BioSpring GmbH, Germany
Bob D. Brown, Ph.D., Senior Vice President, Research, Dicerna Pharmaceuticals, USA
Jesse Z. Dong, Ph.D., Vice President, IPSEN/Biomeasure, Incorporated, USA
Takefumi Gemba, Ph.D., Director, Business Development, SNBL, Ltd., Japan
Robert Hagopian, Director, Business Development, PolyPeptide Laboratories, USA
Peter Hoffmann, Ph.D
Christopher P. Holmes, Ph.D., Executive Director, Chemistry, Affymax, Inc., USA
Jesper Lau, Ph.D., Vice President, Diabetes Protein and Peptide Chemistry, Novo Nordisk, Denmark
Shawn Lee, Ph.D., President and CEO, CPC Scientific, USA and China
Paula Lorence, Vice President, Business Development, Avecia OligoMedicines, USA
Bruce Morimoto, Ph.D., Vice President, Drug Development, Allon Therapeutics, Inc., Canada
Takahiro Nakazawa, Ph.D., Senior Director, Research and Development, Anges MG, Inc., Japan
Satoshi Obika, Professor, Graduate School of Pharmaceutical Sciences, Osaka University, Japan
Dmitry Samarsky, Ph.D., Executive Vice President, Technology Development, RiboBio, China
Hideaki Sato, General Manager, Technical Support & Marketing Division, GeneDesign, Inc., Japan
Daisuke Takahashi, Section Chief, Research Institute for Bioscience products and Fine Chemicals, Ajinomoto Co., Inc., Japan
James D. Thompson, Ph.D., Vice President, Pharmaceutical Development, Quark Pharmaceuticals, Inc., USA
Blake Unterreiner, Business Development Manager, Nucleic Acid Solutions Division, Agilent Technologies, Inc., USA